Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dooley

Showing results (161-170 of 263) with videos related to

Pageof 27
Sort By:
AIDS Research and Therapy|November 26, 2022
Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case seriesChristin Kilcrease, Hasiya Yusuf, Joan Park, et al.
Mayo Clinic Proceedings|January 21, 2026
Achieving Guidelines Within a 24-Hour Movement Paradigm and Risk of Mortality in US AdultsBenjamin D Boudreaux, Chang Xu, Maria A Serafini, et al.
Drugs|December 29, 2024
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art ReviewViolet Chihota, Makaita Gombe, Amita Gupta, et al.
Clinical Pharmacology and Therapeutics|June 10, 2022
Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing RegimensLénaïg Tanneau, Mats O Karlsson, Susan L Rosenkranz, et al.
Nature Reviews. Neurology|September 9, 2017
Tuberculous meningitisRobert J Wilkinson, Ursula Rohlwink, Usha Kant Misra, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteersK E Dooley, E E Bliven-Sizemore, M Weiner, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant TuberculosisPaolo Denti, Anthony J Garcia-Prats, Heather R Draper, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 15, 2026
Development and Validation of Cardiorespiratory Fitness Prediction Equations from 6-Minute Walk Test in the CARDIA StudyBjoern Hornikel, Erin E Dooley, C Barrett Bowling, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 1, 2011
Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267Kelly E Dooley, Jeong-Gun Park, Susan Swindells, et al.
The Lancet. HIV|March 1, 2025
Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort studyAnushka Naidoo, Hylke Waalewijn, Kogieleum Naidoo, et al.
Pageof 27

Showing results (161-170 of 263) with videos related to

Sort By:
Pageof 27
AIDS Research and Therapy|November 26, 2022
Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case seriesChristin Kilcrease, Hasiya Yusuf, Joan Park, et al.
Mayo Clinic Proceedings|January 21, 2026
Achieving Guidelines Within a 24-Hour Movement Paradigm and Risk of Mortality in US AdultsBenjamin D Boudreaux, Chang Xu, Maria A Serafini, et al.
Drugs|December 29, 2024
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art ReviewViolet Chihota, Makaita Gombe, Amita Gupta, et al.
Clinical Pharmacology and Therapeutics|June 10, 2022
Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing RegimensLénaïg Tanneau, Mats O Karlsson, Susan L Rosenkranz, et al.
Nature Reviews. Neurology|September 9, 2017
Tuberculous meningitisRobert J Wilkinson, Ursula Rohlwink, Usha Kant Misra, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteersK E Dooley, E E Bliven-Sizemore, M Weiner, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant TuberculosisPaolo Denti, Anthony J Garcia-Prats, Heather R Draper, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 15, 2026
Development and Validation of Cardiorespiratory Fitness Prediction Equations from 6-Minute Walk Test in the CARDIA StudyBjoern Hornikel, Erin E Dooley, C Barrett Bowling, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 1, 2011
Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267Kelly E Dooley, Jeong-Gun Park, Susan Swindells, et al.
The Lancet. HIV|March 1, 2025
Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort studyAnushka Naidoo, Hylke Waalewijn, Kogieleum Naidoo, et al.
Pageof 27